The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
CRISPR in context: towards a socially responsible debate on embryo editing
Open accessAbstract
Following the birth in 2018 of two babies from embryos altered using CRISPR-Cas9, human germline gene editing (GGE) moved from abstract concern to reality. He Jiankui, the scientist responsible, has been roundly condemned by most scientific, legal and ethical commentators. However, opinions remain divided on whether GGE could be acceptably used in the future, and how, or if it should be prohibited entirely. The many reviews, summits, positions statements and high-level meetings that have accompanied the emergence of CRISPR technology acknowledge this, calling for greater public engagement to help reach a consensus on how to proceed. These calls are laudable but far from unproblematic. Consensus is not only hugely challenging to reach, but difficult to measure and to know when it might be achieved. Engagement is clearly desirable, but engagement strategies need to avoid the limitations of previous encounters between publics and biotechnology. Here we set CRISPR in the context of the biotechnology and fertility industries to illustrate the lessons to be learned. In particular we demonstrate the importance of avoiding a ‘deficit mode’ in which resistance is attributed to a lack of public understanding of science, addressing the separation of technical safety criteria from ethical and social matters, and ensuring the scope of the debate includes the political-economic context in which science is conducted and new products and services are brought to market. Through this history, we draw on Mary Douglas’ classic anthropological notion of ‘matter out of place’ to explain why biotechnologies evoke feelings of unease and anxiety, and recommend this as a model for rehabilitating lay apprehension about novel biological technologies as legitimate matters of concern in future engagement exercises about GGE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“When relevant policies are mentioned, even in scholarly literature, the information provided is typically vague or inaccurate.13,14”
From Human Germline and Heritable Genome Editing: The Global Policy Landscape (2020) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
- Retracted
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
(2023) · doi:10.1126/science · Cited by 6,063
Epistemic Cultures: How the Sciences Make Knowledge
Knorr Cetina, K. (1999) · Harvard University Press eBooks · doi:10.4159/9780674039681 · Cited by 3,956
Epistemic cultures: how the sciences make knowledge
(1999) · Choice Reviews Online · doi:10.5860/choice.37-0887 · Cited by 3,346 · cited 1×
“This combination of a particular way of looking at the world and a set of techniques for producing knowledge based on that perspective is what Karin Knorr-Cetina (1999) described as the peculiar ‘epistemic culture’ of a discipline.”
Douglas, M. (1966) · Cited by 2,762
Biocapital: The Constitution of Postgenomic Life
Sunder Rajan, K. (2006) · Duke University Press eBooks · doi:10.1215/9780822388005 · Cited by 1,067
Biocapital: The Constitution of Postgenomic Life
Rajan, K. S. (2006) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,055
The lure of rationality: Why does the deficit model persist in science communication?
Simis, M. J., Madden, H., Cacciatore, M. A., & Yeo, S. K. (2016) · Public Understanding of Science · doi:10.1177/0963662516629749 · Cited by 739
A prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733
Research works printed but not linked: 6
- Kannegiesser H (1988) Conception in the test tube: the IVF story, How Australia Leads the World. Macmillan, South Melbourne
- National Academy Of Sciences; National Academy Of Medicine (2017) Human Genome Editing: Science, Ethics and Governance. The National Acadamies Press, Washington, DC
- Regalado A (2018c) Rogue Chinese CRISPR scientist cited US report as his green light. MIT Technology Review. Rogue Chinese CRISPR scientist cited US report as his green light. Accessed 15 Aug 2019
- Skloot R (2011) The immortal life of Henrietta Lacks. Broadway Books, New York
- United States President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982) Splicing life: a report on the social and ethical issues of genetic engineering with human beings. The Commission, Washington, DC
- Wipperman A, Campos M (2016) Genome editing technologies: the patient perspective. Genetic Alliance UK, London
Cited by
Human Germline and Heritable Genome Editing: The Global Policy Landscape
Baylis, F., Darnovsky, M., Hasson, K., & Krahn, T. M. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0082 · Cited by 155
“13,14 For example, the September 2020 report on Heritable Human Genome Editing 15 produced by the International Commission on the Clinical Use of Human Germline Genome Editing, a body cosponsored by the U.S. National Academy of Medicine, the U.S. National Academy of Sciences, and the Royal Society…”
Regulatory, Ethical, and Social Aspects of CRISPR Crops
Ahmad, A., Ghouri, M. Z., Munawar, N., Ismail, M., Ashraf, S., & Aftab, S. O. (2021) · Springer eBooks · doi:10.1007/978-981-15-7142-8_9 · Cited by 53
Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges
Abdalla, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i40.4339 · Cited by 25
“The case of CRISPR-edited embryos in China, which led to international outcry, exemplifies the risks and ethical questions surrounding gene editing[129].”
Ramos, P. D., Almeida, M. S., & Olsson, I. A. S. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1284547 · Cited by 24
“…a spike of interest with the advent of the CRISPR-Cas9 technology (National Academy of Sciences, 2017; Nordberg et al., 2018; Brokowski and Adli, 2019; Morrison and de Saille, 2019), and the ethical issues are discussed by the general public and the scienti fi c community in distinct ways.”
BackgroundInfluentialEvans, J. H. (2024) · doi:10.1093/oso/9780197750704.001.0001 · Cited by 36
Metadata
- Authors
- Morrison, M., & de Saille, S.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Morrison, Michael
- ORCID
- Morrison, Michael
- Venue
- Palgrave Communications
- Published
- 2019-09-24
- Volume
- 5
- Issue
- 1
- ISSN
- 2055-1045 (ISSN-L)
- OpenAlex
- W2975522953
- Cited by
- 62
- References
- 64
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 14 · 2023: 18 · 2022: 6 · 2021: 10 · 2020: 4
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Humanities and Social Sciences Communications (publishedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Economic and Social Research Council (ES/P002943/1)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Bioethics and Human Rights Issues
- Keywords
- CRISPR/Cas9, germline editing, embryo editing, public engagement with science, deficit model, Mary Douglas, ethics of biotechnology, fertility industry, biotechnology regulation, He Jiankui, social responsibility, political economy of science
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CRISPR in context: towards a socially responsible debate on embryo editing. https://app.cochat.ai/papers/10.1057/s41599-019-0319-5
- The paper
- Morrison, M., & de Saille, S. (2019). CRISPR in context: towards a socially responsible debate on embryo editing. Palgrave Communications. https://doi.org/10.1057/s41599-019-0319-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.